AstraZeneca reports SERENA-6 trial shows improvement in the primary endpoint
Results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s (AZN) camizestrant in combination with a ...
AstraZeneca announces results from interim analysis of SERENA-6 Phase III trial
Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s (AZN) camizestrant in ...
Cure Today2d
Camizestrant Combo Improves Progression Time in HR+/HER2– Breast Cancer
Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...
BioSpace5d
AstraZeneca Posts Positive Phase III Results for Oral Breast Cancer Drug
In the Phase III SERENA-6 trial, camizestrant—in combination with CDK-inhibitors—beat out current standard-of-care treatments ...
Serena Williams takes ownership stake in WNBA's Toronto Tempo
Retired tennis great Serena Williams has taken an ownership stake in Canada's first Women's National Basketball Association ...